glycine has been researched along with Crush Syndrome in 1 studies
Crush Syndrome: Severe systemic manifestation of trauma and ischemia involving soft tissues, principally skeletal muscle, due to prolonged severe crushing. It leads to increased permeability of the cell membrane and to the release of potassium, enzymes, and myoglobin from within cells. Ischemic renal dysfunction secondary to hypotension and diminished renal perfusion results in acute tubular necrosis and uremia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with sivelestat significantly improved survival rate with P = 0." | 1.39 | Sivelestat improves outcome of crush injury by inhibiting high-mobility group box 1 in rats. ( Abe, C; Binh, NH; Cuong, NT; Hara, A; Morita, H; Ogura, S, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuong, NT | 1 |
| Abe, C | 1 |
| Binh, NH | 1 |
| Hara, A | 1 |
| Morita, H | 1 |
| Ogura, S | 1 |
1 other study available for glycine and Crush Syndrome
| Article | Year |
|---|---|
Sivelestat improves outcome of crush injury by inhibiting high-mobility group box 1 in rats.
Topics: Acute Lung Injury; Animals; Biomarkers; Carbon Dioxide; Combined Modality Therapy; Crush Syndrome; D | 2013 |